Copyright
©2010 Baishideng.
World J Gastroenterol. Jun 28, 2010; 16(24): 3025-3032
Published online Jun 28, 2010. doi: 10.3748/wjg.v16.i24.3025
Published online Jun 28, 2010. doi: 10.3748/wjg.v16.i24.3025
OR | 95% CI | P | |
Control group | |||
Age ≥ 65 yr | 0.873 | 0.606-1.259 | 0.4675 |
BMI ≥ 25 kg/m2 | 1.048 | 0.769-1.426 | 0.7681 |
Alcohol abuse | 22.069 | 13.749-35.425 | < 0.0001 |
DM2 | 2.507 | 1.703-3.692 | < 0.0001 |
LC group | |||
Age ≥ 65 yr | 2.457 | 1.855-3.252 | < 0.0001 |
BMI ≥ 25 kg/m2 | 1.560 | 1.197-2.032 | 0.0010 |
HBV positive | 2.372 | 1.363-4.127 | 0.0022 |
HCV positive | 2.783 | 1.896-4.084 | < 0.0001 |
Alcohol abuse | 1.937 | 1.318-2.845 | 0.0008 |
ALT ≥ 53 IU/L | 0.919 | 0.672-1.256 | 0.5951 |
DM2 | 1.456 | 1.072-1.979 | 0.0162 |
- Citation: Donadon V, Balbi M, Valent F, Avogaro A. Glycated hemoglobin and antidiabetic strategies as risk factors for hepatocellular carcinoma. World J Gastroenterol 2010; 16(24): 3025-3032
- URL: https://www.wjgnet.com/1007-9327/full/v16/i24/3025.htm
- DOI: https://dx.doi.org/10.3748/wjg.v16.i24.3025